Viage Therapeutics

About:

Viage Therapeutics is a biotech company that develops therapeutics that stimulates the central nervous system via the gut-brain axis.

Website: https://viagetx.com

Top Investors: ANRI, Kyoto University Innovation Capital, Remiges Ventures, Miyako Capital, Zhongze

Description:

Viage Therapeutics, a neuroscience company based on a platform of novel neurotherapeutics, was founded in 2018. The company is based on the ground-breaking research.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)viagetx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-01-06

IPO Status:

Private

Industries: